Drug company executives plot strategy for maintaining monopoly after Democrats take over Congress: NewsTarget.com

Pharmaceutical Research and Manufacturers of America (PhRMA) -- a drug industry lobbying group -- held a meeting in Washington, D.C. last month following midterm elections to draft a plan of action to retain political sway in the Democrat-controlled U.S. Congress.

PhRMA president Billy Tauzin and other members of the organization met with a number of Democratic senators and representatives, urging them to seek positions as chairs of influential subcommittees with authority over Medicare and drug industry regulations.

Tauzin also met with a number of Democrats who have supported legislation on issues such as allowing imports of cheaper brand-name drugs from Canada, authorizing Medicare to negotiate cheaper prescription drug prices with manufacturers and restricting direct-to-consumer drug advertising.

The conclusion of this article appears on NewsTarget.com, the independent natural health news source for consumers. This article, along with other uncensored news on important consumer health topics, can be found at:

Drug company executives plot strategy for maintaining pharmaceutical monopoly after Democrats take over Congress

http://www.newstarget.com/021249.html

About NewsTarget

Read by over 500,000 unique readers monthly, NewsTarget is a progressive, independent natural health news site that teaches consumers how to improve their health through foods, herbs, exercise and natural therapies. The site also warns consumers about the dangers of processed foods, pharmaceuticals, chemotherapy, environmental toxins and the failure of government regulators like the FDA.